tiprankstipranks
Evonik (GB:0QDS)
LSE:0QDS

Evonik (0QDS) Technical Analysis

3 Followers

Technical Sentiment

Overall Consensus
Strong Buy
17Bullish
5Neutral
0Bearish
Technical Analysis Consensus
Buy
5Bullish
5Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Evonik’s (0QDS) Moving Averages Convergence Divergence (MACD) indicator is 0.09, suggesting Evonik is a Buy.
Evonik’s (0QDS) 20-Day exponential moving average is 18.93, while Evonik’s (0QDS) share price is €19.077, making it a Buy.
Evonik’s (0QDS) 50-Day exponential moving average is 18.64, while Evonik’s (0QDS) share price is €19.077, making it a Buy.

Evonik (0QDS) Pivot Points

Jul 04, 2024, 05:17 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
18.28
18.48
18.60
18.80
18.93
19.13
19.25
Fibonacci
18.48
18.60
18.68
18.80
18.93
19.00
19.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Evonik (0QDS) Moving Averages

Jul 04, 2024, 05:17 PM
Period
Simple
Exponential
MA5
19.04Buy
19.00Buy
MA10
19.06Buy
18.99Buy
MA20
18.85Buy
18.93Buy
MA50
18.81Buy
18.64Buy
MA100
17.81Buy
18.11Buy
MA200
17.13Buy
17.53Buy
Evonik’s (0QDS) 10-Day exponential moving average is 18.99, while Evonik’s (0QDS) share price is €19.077, making it a Buy.
Evonik’s (0QDS) 100-Day exponential moving average is 18.11, while Evonik’s (0QDS) share price is €19.077, making it a Buy.
Evonik’s (0QDS) stock price is €19.077 and Evonik’s (0QDS) 50-day simple moving average is 18.81, creating a Buy signal.
Evonik’s (0QDS) stock price is €19.077 and Evonik’s (0QDS) 100-day simple moving average is 17.81, creating a Buy signal.
Evonik’s (0QDS) stock price is €19.077 and Evonik’s (0QDS) 200-day simple moving average is 17.13, creating a Buy signal.

Evonik (0QDS) Technical Indicators

Jul 04, 2024, 05:17 PM
Name
Value
Implied Action
RSI (14)
53.93
Neutral
STOCH (9,6)
28.62
Neutral
STOCHRSI (14)
58.85
Neutral
MACD (12,26)
0.09
Buy
ADX (14)
14.62
Buy
Williams %R
-30.47
Buy
CCI (14)
46.91
Neutral
ATR (14)
0.61
-
Ultimate Oscillator
39.61
Neutral
ROC
1.92
Buy
Evonik’s (0QDS) Relative Strength Index (RSI) is 53.93, creating a Neutral signal.
Evonik’s (0QDS) Trend Strength Indicator (ADX) is 14.62, creating a Buy signal.
Evonik’s (0QDS) Commodity Channel Index (CCI) is 46.91, creating a Neutral signal.
Evonik’s (0QDS) Price Rate of Change (ROC) is 1.92, creating a Buy signal.

FAQ

Is 0QDS a Buy, Hold, or Sell?
Based on 0QDS’s technical indicators, 0QDS is a Strong Buy.
    What is 0QDS’s RSI (14)?
    0QDS’s RSI (14) is 53.93, which suggests 0QDS is a Neutral.
      What is 0QDS’s MACD?
      0QDS’s MACD is 0.09, which suggests 0QDS is a Buy.
        What is 0QDS’s 5-day moving average?
        0QDS’s 5-day moving average is 19.04, which suggests 0QDS is a Buy.
          What is 0QDS’s 20-day moving average?
          0QDS 20-day moving average is 18.85, which suggests 0QDS is a Buy.
            What is 0QDS’s 50-day moving average?
            0QDS’s 50-day moving average is 18.81, which suggests 0QDS is a Buy.
              What is 0QDS’s 200-day moving average?
              0QDS’s 200-day moving average is 17.13, which suggests 0QDS is a Buy.
                What is 0QDS’s Williams % R (14)?
                0QDS’s Williams % R (14) is -30.47, which suggests 0QDS is a Buy.
                  What is 0QDS’s CCI (14)?
                  0QDS’s CCI (14) is 46.91, which suggests 0QDS is a Neutral.
                    What is the share price of Evonik?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis